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model but it is likely that other autoantigens are involvedId3 Knockout Mice as a New Model
in the disease process.for Sjo¨gren’s Syndrome: The novelty of the Id3-deficient mouse as a model for
Sjo¨gren’s Syndrome, described in this issue of ImmunityOnly a T Cell Defect or More?
by Li et al. (2004), is that the disease arises due to
the absence of a single nuclear protein and involves
lymphocytic infiltration of only the exocrine glands. In-
Id3/ mice were found to have autoantibodies, lym- terestingly, the disease symptoms occur when the mice
phocytic infiltrates in, and decreased secretion by exo- reach an age comparable to human middle age, the usual
crine glands. Similar symptoms are found in primary period when symptoms of Sjo¨gren’s Syndrome manifest.
Sjo¨gren’s Syndrome. In this issue of Immunity, Li and Id3 is an inhibitor of basic-helix-loop-helix protein
colleagues (Li et al., 2004) suggest an important role transcription factors, which are important for cellular
for Id3 function in T cell development and Sjo¨gren’s differentiation and proliferation. In the immune system,
Id3 plays a role in signaling by the (pre-)T cell receptorSyndrome.
as well as the B cell receptor. Absence of Id3 results
in a decreased humoral response and impaired T cellPrimary Sjo¨gren’s Syndrome is a systemic autoimmune
selection (Pan et al., 1999). Now, Li et al. clearly showdisease in which the salivary and lacrimal glands are
by adoptive T cell transfer a role for Id3-deficient T cellspredominantly affected. A focal lymphocytic infiltrate of
as effector cells in Sjo¨gren’s-like symptoms in Id3-defi-mainly CD4 T cells is found in these glands in affected
cient mice. As Id3-deficiency results in abnormal T cellindividuals. This chronic inflammatory process leads,
selection and function, the presence of autoreactivedirectly or indirectly, to diminished gland function re-
T cells in the periphery will be likely. However, can defi-sulting in symptoms of dry mouth and dry eyes. Like
ciencies in other cell types be involved as well? Dendriticother autoimmune diseases, Sjo¨gren’s Syndrome is con-
cells infiltrate the salivary glands of NOD mice beforesidered a multigenic and multifactorial disease. About 1%
the lymphocytes, while control mice and MRL/Ipr miceof the population is affected, 90% of whom are female.
do not exhibit increased numbers of dendritic cells (vanSjo¨gren’s Syndrome is difficult to diagnose in its early
Blokland et al., 2000). Id3 also plays a role in the develop-stages due to heterogeneity in clinical appearance.
ment of NK cell and plasmacytoid dendritic cells (pDC)Many patients have had multiple investigations in sev-
(Heemskerk et al., 1997; Spits et al., 2000). Interestingly,eral hospitals before the proper diagnosis is made.
plasmacytoid DC have been claimed to induce toleranceTherefore, there is a clear need for specific markers for
against common environmental antigens in the lung (dedetection of early disease.
Heer et al., 2004). Furthermore, data are accumulatingAnimal models are powerful tools for the study of the
that pDC have a pivotal role in autoimmunity. Therefore,
pathogenesis of autoimmune diseases. For Sjo¨gren’s
it can be envisaged that Id3-deficiency results in abnor-
Syndrome, the most extensively studied model is the
malities in pDC development, leading to deficient induc-
NOD mouse, also used as a model for type I diabetes. tion of tolerance.
NOD mice spontaneously develop lymphocytic infil- The Id3/ model offers a wonderful opportunity to
trates in exocrine glands (sialoadenitis and dacryoade- study in detail the relationship between the various cells
nitis) coinciding with a disturbed secretory function. The of the immune system and autoimmunity occurring in
development of diabetes in NOD mice is independent the context of only a single genetic lesion. One question
from sialoadenitis but studies of the complex genetics that arises is why the infiltrates in these mutant animals
revealed the involvement of several susceptibility loci occur specifically in the salivary and lacrimal glands and
for diabetes in the development of sialoadenitis. The not in other tissues. Earlier studies in the NOD mouse
MRL/lpr mouse is also used as a model for Sjogren’s model for Sjo¨gren’s Syndrome indicated that abnormal
Syndrome. However, the coexistence of sialoadenitis organogenesis during salivary gland development might
with a lupus-like phenotype renders this mouse a model initiate the adult onset of autoimmune sialoadenitis (Cha
for secondary Sjo¨gren’s Syndrome, a disease in which et al., 2001). Further support for the hypothesis that
Sjo¨gren’s Syndrome and a systemic autoimmune dis- aberrations in the target organ in addition to abnormali-
ease like SLE or rheumatoid arthritis occur together. ties in the immune system are required can be found in
Furthermore, there is no loss in secretory function in the the 3d-Tx NFS/sld mice, where disease develops exclu-
MRL/lpr mouse. Another interesting model for Sjo¨gren’s sively when both prerequisites are met. Id3 is an impor-
Syndrome in which loss of secretory function is seen is tant protein in development and differentiation. Interest-
the NFS/sld mouse (Haneji et al., 1994). This strain has a ingly, Id3 has been identified as a Smad4-dependent
spontaneous autosomal recessive mutation that affects TGF- responsive gene (Kowanetz et al., 2004). TGF-
the differentiation of the sublingual gland, resulting in is involved in salivary gland development and it can be
sialoadenitis after thymectomy at 3 days of age. These imagined that Id3 deficiency might result in abnormal
3d-Tx NFS/sld mice develop lymphocytic infiltrates in organogenesis. Therefore, it is tempting to speculate
the exocrine glands, but not in other organs. The only that in Id3/ mice, the organogenesis of the exocrine
candidate autoantigen known so far for Sjo¨gren’s Syn- glands is disturbed and results in aberrant presentation
of autoantigens capable of stimulating highly responsivedrome, 120 kDa -fodrin, has been identified in this
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them about their homing preference; upon systemicRetinoic Acid:
stimulation by antigen, activated T cells in mesentericAn Educational “Vitamin Elixir” lymph nodes (MLN; receiving afferent lymph from the
for Gut-Seeking T Cells gut) upregulate gut-homing molecules, whereas those
in peripheral lymph nodes (PLN, draining cutaneous tis-
sues) express skin-homing receptors (Campbell and
Butcher, 2002). This differential imprinting was repro-
duced in vitro by activating naive T cells with DC fromT cell priming by dendritic cells (DC) from gut-associ-
different lymphoid organs. Thus, DC from Peyer’sated lymphoid tissues gives rise to effector cells with
patches (PP) or MLN, but not from PLN or spleen, inducepronounced gut tropism. The mechanism for DC-depen-
effector T cells with high expression of 47 and CCR9dent imprinting of gut specificity has remained un-
and the capacity to migrate to the small bowel (Johans-known. New findings point to retinoic acid, which is
uniquely produced by intestinal DC, but not by DC son-Lindbom et al., 2003; Mora et al., 2003; Stagg et
from other lymphoid organs (Iwata et al., 2004; this al., 2002). However, until now, the mechanism(s) respon-
issue of Immunity). sible for this imprinting of tissue specificity has remained
a complete mystery.
A groundbreaking article in this issue of ImmunityWhen naive T cells are activated by antigen they become
identifies the first molecular mechanism for the im-effector/memory T cells, which acquire the capacity to
printing of gut-homing T cells (Iwata et al., 2004). Inmigrate to extralymphoid tissues (von Andrian and
an elegant series of experiments, Iwata and colleaguesMackay, 2000). Effector cells that arise in response to
show that T cell exposure to subnanomolar concentra-antigens in the alimentary tract express mostly intestinal
tions of the vitamin A metabolite retinoic acid (RA) in-homing receptors, particularly the integrin 47 and
duced gut-homing receptors and the ability to migrateCCR9, the receptor for TECK/CCL25, a chemokine ex-
to the small intestine while simultaneously suppressingpressed in the small bowel. Consequently, these cells
the expression of skin-homing molecules. These effectsmigrate preferentially to the small intestine, whereas
were reproduced with a synthetic agonist on RA recep-T cell stimulation by cutaneous antigens induces ef-
tors of the RAR isotype. Importantly, many DC from PPfector cells expressing skin-homing receptors, such as
and MLN but few from PLN or the spleen expressed thecarbohydrate ligands for endothelial P- and E-selectin
prerequisite enzymes for oxidative conversion of vitaminand the chemokine receptors CCR4 and/or CCR10.
A to RA, and inhibitors of these enzymes rendered intes-In vivo studies have shown that the microenvironment
in which T cells encounter antigen somehow instructs tinal DC incapable of inducing 47high T cells. Consis-
